[Etiopathogenesis, diagnostics and treatment of osteoporosis at inflammatory bowel diseases].
Osteoporosis and related osteoporotic bone fractures are more and more becoming causes of disability for many categories of patients leading to the reduction of their life quality as well as high direct and indirect material expenses. This is true in full measure for patients with inflammatory bowel diseases (IBD) who experience a negative effect produced on the mineral density of bone tissue by long-term chronic inflammation, impaired calcium and vitamin D absorption, hypotrophy and, finally, therapy with glucocorticoids. This stimulates clinicians to develop actively the osteoporosis screening methods for patients with IBD as well as methods of its prevention and treatment.